Formulary Digital Edition, June 2010

News
Article

Pulmonary arterial hypertension: Bridging the gap between efficacy, quality of life, and cost-effectiveness; Lorcaserin: A novel, selective 5-HT2C-receptor agonist for the treatment of obesity; Vaccine agents in late-stage development.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.